Abstract
Patients with Type 2, non-insulin dependent diabetes (NIDDM) exhibit elevated plasma proinsulin to insulin ratios [1–9]. Recently, it has been shown that the plasma proinsulin-like fraction in these patients as well as in normal individuals is comprised of both proinsulin and partially cleaved proinsulin, primarily des 31, 32 proinsulin [7,8]. It is assumed that the elevated ratio between proinsulin-related peptides and insulin reflects a β-cell abnormality, since the metabolic clearance rate of these peptides does not differ appreciably between normal individuals and patients with diabetes [10]. Reduction of the plasma glucose concentration in patients with NIDDM, irrespective of the means, was shown to improve insulin production and reduce the degree of hyperproinsulinaemia [3, 11–15]. These observations in man, as well as studies in animal models of diabetes [16–23] have led to the notion that hyperglycaemia per se might be implicated in the generation of a defective β-cell secretory response [24]. Alternatively, hyperglycaemia may play an important contributory role by amplifying a genetically determined β-cell defect, which may not be apparent until unmasked by a chronic increase in secretory demand.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Duckworth, W. C., Solomon, S. S., and Kitabchi, A. E., 1972, Effect of chronic sulfonylurea therapy on plasma insulin and proinsulin levels, J. Clin. Endocrinol. Metab. 35:585–591.
Gorden, P., Hendricks, C. M., and Roth, J., 1974, Circulating proinsulin-like component in man: increased proportion in hypoinsulinaemic states., Diabetologia 10:469–474.
Mako, S. E., Starr, J. I., and Rubenstein, A. H., 1977, Circulating proinsulin in patients with maturity onset diabetes, Am. J. Med. 63:865–869.
Ward, W. K., LaCava, E. C., Paquette, T. L., Beard, J. C., Wallum, B. J., and Porte, D. Jr., 1987, Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance, Diabetologia 30:698–702.
Yoshioka, N., Kuzuya, T., Matsuda, A., Taniguchi, M., and Iwamoto, Y., 1988, Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia 31:355–360.
Deacon, C. F., Schleser, M. S., Ballmann, M., Willms, B., Conlon, J. M., and Creutzfeldt, W., 1988, Preferential release of proinsulin relative to insulin in non-insulin-dependent diabetes mellitus, Acta Endocrinol (Copenh) 119:549–554.
Temple, R. C., Carrington, C. A., Luzio, S. D., Owens, D. R., Schneider, A. E., Sobey, W. J., and Hales, C. N., 1989, Insulin deficiency in non-insulin-dependent diabetes, Lancet 1:293–295.
Clark, P. M., Levy, J. C., Cox, L., Burnett, M., Turner, R. C., and Hales, C. N., 1992, Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects, Diabetologia 35:469–474.
Levy, J. C., Clark, P. M, Hales, C. N., and Turner, R. C., 1993, Normal proinsulin responses to glucose in mild type II subjects with subnormal insulin response, Diabetes 42:162–169.
Glauber, H. S., Henry, R. R., Wallace, P., Frank, B. H., Galloway, J. A., Cohen, R. M., and Olefsky, J. M., 1987, The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus, N. Engl. J. Med. 316:443–449.
Kosaka, K., Kuzuya, T., Akanuma, Y, and Hagura, R., 1980, Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment, Diabetologia 18:23–28.
Hidaka, H., Nagulesparan, M., Klimes, I., Clark, R., Sasaki, H., Aronoff, S.L., Vasquez, B., Rubenstein, A.H., and Unger, R.H., 1982, Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics, J. Clin. Endocrinol. Metab. 54:217–222.
Vague, P., and Moulin, J. P., 1982, The defective glucose sensitivity of B-cell in non-insulin dependent diabetes: improvement after twenty hours normoglycemia, Metabolism 31:139–142.
Glaser, B., Leibovich, G., Nesher, R., Hartling, S., Binder, C., and Cerasi, E., 1988, Improved beta-cell function after intensive insulin treatment in severe non-insulin-dependent diabetes, Acta Endocrinol (Copenh) 118:365–373.
Yoshioka, N., Kuzuya, T., Matsuda, A., and Iwamoto, Y., 1989, Effect of dietary treatment on serum insulin and proinsulin response in newly diagnosed NIDDM, Diabetes 38:262–266.
Bonner-Weir, S., Trent, D. F., and Weir, G. C., 1983, Partial pancreatectomy in the rat and subsequent defect in glucose induced insulin release, J. Clin. Invest. 71:1544–1553.
Grill, V., and Rundfeldt, M., 1986, Abnormalities of insulin responses after ambient and previous exposure to glucose in streptozotocin-diabetes and dexamethasone-treated rats. Role of hyperglycemia and increased B-cell demands, Diabetes 35:44–51.
Leahy, J. L., Cooper, H. E., Deary, D. A., and Weir, G. C., 1986, Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. A study in normal rats using chronic in vivo glucose infusions, J. Clin. Invest. 77:908–915.
Kergoat, M., Bailbe, D., and Portha, B., 1987, Insulin treatment improves glucose-induced insulin release in rats with NIDDM induced by streptozocin, Diabetes 36:971–977.
Rossetti, L., Shulman, G. I., Zawalich, W., and DeFronzo, R. A., 1987, Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats, J. Clin. Invest. 80:1037–1044.
Leahy, J. L., Halban, P. A., and Weir, G. C., 1991, Relative hypersecretion of proinsulin in rat model of NIDDM, Diabetes 40:985–989.
Leahy, J. L., and Weir, G. C., 1991, Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level, Diabetologia 34:640–647.
Leahy, J. L., 1993, Increased proinsulin/insulin ratio in pancreas extracts of hyperglycemic rats, Diabetes 42:22–27.
Unger, R. H., and Grundy, S., 1985, Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for management of diabetes, Diabetologia 28:119–121.
Adler, J. H., Kaiman, R., Lazarovici, G., Bar-On, H., and Ziv, E., Achieving predictable model of type 2 diabetes in the sand rat, in Lessons from Animal Diabetes III, E. Shafrir, Editor. 1991, Smith-Gordon: London, p. 212–214.
Shafrir, E., and Gutman, A., 1993, Psammomys obesus of the Jerusalem colony: A model for nutritionally induced non-insulin-dependent diabetes, J. Basic Clin. Physiol. Pharmacol. 4:83–99.
Kalderon, B., Gutman, A., Levy, E., Shafrir, E., and Adler, J. H., 1986, Characterization of stages in development of obesity-diabetes syndrome in the sand rat (Psammomys obesus), Diabetes 35:717–723.
Marquie, G., Duhault, J., and Jacotot, B., 1984, Diabetes mellitus in sand rats (Psammomys obesus). Metabolic pattern during development of the diabetic syndrome, Diabetes 33:438–443.
Kanety, H., Moshe, S., Shafrir, E., Lunenfeld, B., and Karasik, A., 1994, Hyperinsulinemia induces a reversible impairment in insulin receptor function leading to diabetes in the sand rat model of NIDDM, Proc. Natl. Acad. Sci. USA 91:1853–1857.
Kaiman, R., Ziv, E., Adler, J. H., Lazarovici, G., and Bar-On, H., 1993, The efficiency of the sand rat metabolism is responsible for the development of obesity and diabetes, J. Basic Clin. Physiol. Pharmacol. 4:57–68.
Kahn, S. E., McCulloch, D. K., Schwartz, M. W., Palmer, J. P., and Porte, D. J., 1992, Effect of insulin resistance and hyperglycemia on proinsulin release in a primate model of diabetes mellitus, J. Clin. Endocrinol. Metab. 74:192–197.
Lacy, P. E., and Kostianovsky, M., 1967, Method for the isolation of intact islets of Langerhans from rat pancreas, Diabetes 16:35–39.
Kaiser, N., Coreos, A. P., Tur-Sinai, A., Ariav, Y., and Cerasi, E., 1988, Monolayer culture of adult pancreatic islets on extracellular matrix: Long term maintenance of differentiated B-cell function, Endocrinology 123:834–840.
Gadot, M., Leibowitz, G., Shafrir, E., Cerasi, E., Gross, D. J., and Kaiser, N., 1994, Hyperproinsulinemia and insulin deficiency in the diabetic Psammomys obesus, Endocrinology 135:610–616.
Seino, S., Fu, Z. Z., Marks, W., Seino, Y., Imura, H., and Vinik, A., 1986, Characterization of circulating insulin in insulin autoimmune syndrome, J. Clin. Endocrinol. Metab. 62:64–69.
Cohen, R. M., et al., 1986, Proinsulin radioimmunoassay in the evaluation of insulinomas and familial hyperproinsulinemia, Metabolism 35:1137–1146.
DeFronzo, R. A., 1988, The triumvirate: β-cell, muscle, liver. A collusion responsible for NIDDM, Diabetes 37:667–687.
DeFronzo, R. A., Bonadonna, R. C., and Ferrannini, E., 1992, Pathogenesis of NIDDM: A balanced overview, Diabetes Care 15:318–368.
Bennett, P. H., Rushforth, N. B., Miller, M., and LeCompte, P. M., 1976, Epidemiologie studies of diabetes in the Pima Indians, Recent Progr. Horm. Res. 32:333–376.
Cook, D. L., and Taborsky, J. G. J., B-cell function and insulin secretion, in Diabetes Mellitus. Theory and Practice, H. Rifkin and J.D. Porte, Editor. 1990, Elsevier Science Publ. Co., Inc.: New York. p. 86–103.
Like, A. A., and Miki, E., 1967, Diabetic syndrome in sand rats IV. Morphologic changes in islet tissue, Diabetologia 3:146–166.
Porte, D., Jr., 1991, Banting lecture 1990: β-cells in type II diabetes mellitus, Diabetes 40:166–180.
Leahy, J. L., Bumbalo, L. M., and Chen, C., 1993, Beta-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats, Diabetologia 36:1238–1244.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kaiser, N., Gadot, M., Leibowitz, G., Cerasi, E., Gross, D.J. (1997). Hyperproinsulinaemia and Islet Dysfuction in the NIDDM-Like Syndrome of Psammomys obesus . In: Soria, B. (eds) Physiology and Pathophysiology of the Islets of Langerhans. Advances in Experimental Medicine and Biology, vol 426. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1819-2_49
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1819-2_49
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1821-5
Online ISBN: 978-1-4899-1819-2
eBook Packages: Springer Book Archive